This Market Is Not Slowing Down
The opportunistic bulls are finding plenty of profitable action.
7 Ways to Invest in the Future of Cannabis
Leading advisors pick four favorite cannabis purveyors, two marijuana ETFs and one ancillary tobacco segment firm.
I See Some Magic Happening as Psilocybin Advances
New technology could take out some of the pain -- and subjectivity -- for those looking to invest in this emerging line of treatments.
For Burned Out Cannabis Investors, Here's Hit of Optimism and a Trade Idea
If you have a trader's mentality, there's a setup here worth watching.
I'm Interested in Constellation Brands, Just Not in Love
Question: Would you rather buy the beer or the stock?
This New ETF Is Totally a Wild
AdvisorShares Psychedelics ETF, which is adding Mindset Pharma and lists Cybin as a top holding, looks like a good trip.
Evergrande Fears Ease as the Market Looks Ahead to the Fed Decision
I'm looking for a continuation of strong pockets of speculative action.
A 'Trip' to the Boardroom: A Look at Psychedelic Med's Top Players
To help readers navigate this mushrooming opportunity, I've put together a list of the top corporate leaders in the field.
Here's Why I'm a Buyer of Grove Inc
GRVI caters to multiple market segments like Beauty, Pet Care, Botanical Health & Wellness, Rare Cannabinoids, and even trade shows.
Cannabis Stocks Are Lighting Up Investors' Portfolios
ETF MSOS is seen as an opportunity to get exposure to stocks that are not yet U.S. listed.